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into the clinical practice of orthotopic heart transplanta-
tion in 1991. 
The theoretic advantage of this alternative technique
is to retain normal-shaped atria, which may preserve
atrial contractility and sinus node function and may
maintain the atrioventricular valve competence.4,5
The influence of the bicaval technique on hemody-
namics, right atrial (RA) contractility, and right ventric-
ular dimension during the early postoperative period
has been previously described.6-8 This study was
designed to compare the medium-term difference
between the standard and the bicaval techniques for
orthotopic heart transplantation and to demonstrate any
long-term advantages of RA preservation on right-sided
output that optimizes right-sided cardiac pressure. We
also compared the left ventricular performance and
actuarial survival after the introduction of the bicaval
technique into the clinical practice of orthotopic heart
transplantation.
O rthotopic heart transplantation is a well-establishedmethod for treatment of end-stage heart failure.
Most orthotopic heart transplantation procedures have
been performed according to the technique described by
Sarsam and colleagues1 and by Lower, Stofer, and
Shumway.2 The bicaval technique3 with a small left
atrial cuff and cavoatrial anastomoses was introduced
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BICAVAL AND STANDARD TECHNIQUES IN ORTHOTOPIC HEART TRANSPLANTATION: 
MEDIUM-TERM EXPERIENCE IN CARDIAC PERFORMANCE AND SURVIVAL
Methods
Patient characteristics. The patient population consisted
of 201 heart transplant recipients (mean age, 49 ± 10 years;
range, 12-62 years); 39 women and 162 men who underwent
orthotopic heart transplantation between 1991 and 1997 at
Wythenshawe Hospital, Manchester, United Kingdom. The
preoperative pathologic condition of the whole study group is
listed in Table I. 
Patients were allocated on an alternate basis to undergo
operation by either the bicaval Wythenshawe1 technique (n =
96 patients) or the standard technique of Lower,2 Shumway,3
and their colleagues (n = 105 patients). For a temporary peri-
od of 6 months (December 1993 through June 1994), the
operative technique was determined by coin tossing. Patients
undergoing retransplantation, patients receiving domino
hearts (very short superior vena cava and difficult to perform
superior vena cava anastomosis), and patients in whom per-
formance of bicaval anastomosis was technically difficult
(high diaphragm or other chest cavity anomalies) were
excluded from the study. There was no difference in mean
preoperative pulmonary hemodynamics, age, ischemic time,
and postoperative incidence of rejection between the 2
groups. Follow-up was completed on April 1998 or at the
time of the recipient’s death, thus giving a minimum follow-
up of 12 months for all surviving patients.
Postoperative management. All patients received isopro-
terenol (INN: isoprenaline) intravenously for a minimum of 3
days as part of our routine postoperative protocol. Other car-
diac inotropic or mechanical supports (intra-aortic balloon
pump or right-sided ventricular assist device) were used
whenever clinically indicated in both groups. Triple-drug
immunosuppression with cyclosporine (INN: ciclosporin),
azathioprine, and corticosteroids was used in all patients in
addition to an initial 3-day dose of cytolytic induction thera-
py. Surveillance endomyocardial biopsies (EMBs) were per-
formed on a scheduled basis (weekly for the first month; every
2 weeks for the next 2 months; monthly up to 6 months; at 9,
12, and 18 months after the transplantation; and annually there-
after). If rejection was suspected on clinical grounds in the
interim, supplementary biopsies were performed accordingly.
Surgical techniques. The standard technique was per-
formed as described by Lower,2 Shumway,3 and their col-
leagues. The bicaval technique was performed as previously
described by Sarsam and colleagues.1 In brief, the right atri-
um of the recipient is excised, leaving behind a 2- to 3-cm
cuff around each cava (cavoatrial cuff). The left atrial incision
is carried to the base of the left atrial appendage, which is
removed leaving a small margin of the atrial cuff around 4
pulmonary veins. The donor hearts are excised with an intact
right atrium and long cava. Donor hearts are arrested with
cold St Thomas’ Hospital cardioplegic solution and stored in
4°C cold saline solution. The donor left atrium is sutured to
the recipient left atrium in the usual fashion before the inferi-
or vena cava and the superior vena cava are sutured to the
recipient cavoatrial cuff. The aorta and pulmonary arteries are
sutured in the usual way. 
Endomyocardial biopsy and right heart catheteriza-
tion. The policy at our institution is for EMBs to be per-
formed with a Stanford-Caves bioptome, usually through a
percutaneous right internal jugular approach. Right heart
catheterization is performed with a Swan-Ganz catheter
(Baxter Healthcare Corp, Edwards Division, Santa Ana,
Calif) or a multipurpose Cordis 7F vascular catheter (Cordis,
Miami, Fla) connected to an AE 840 pressure transducer
(Mikro Elektronik K A/S) during each biopsy up to 12
months after the transplantation, when previous EMB reports
indicate cellular rejection of grade 2 or more or whenever
there was a clinical suggestion of rejection. For the purposes
of the present study, right heart pressure assessment was per-
formed according to our usual protocol. At different study
periods (except the 4-week periods), right-sided cardiac pres-
sure measurements were made, provided there had been no
histologic evidence of rejection within the preceding 3
months. Hemodynamic assessment was only considered in
the absence of rejection (ie, International Society for Heart
and Lung Transplantation grade 0). All patients were in sinus
rhythm without cardiac pacing at the time of assessment.
Echocardiography. Comprehensive transthoracic echo-
cardiography (with color flow mapping) was performed in
each patient at the same time as EMBs up to the end of the
first year after the transplantation, and then every 6 months or
when clinically indicated. The examination was performed
with patients in the left lateral decubitus position in quiet res-
piration after 5 minutes of rest with a machine (Sonos
2000/2500; Hewlett-Packard Company, Andover, Mass)
equipped with a 2.5 MHz transducer. An experienced
echocardiographer who was unaware of the surgical tech-
nique as part of the routine echocardiographic evaluation per-
formed each study. The assessment of left ventricular func-
tion was on a semiquantitative basis with visual estimation of
ejection fraction after imaging of the left ventricular
myocardium in the parasternal long-axis and short-axis views
and the apical 4-chamber and long-axis views. The tricuspid
valve was interrogated in the parasternal short-axis and apical
4-chamber views. Color flow Doppler examinations were
performed with as narrow a sector angle as possible to maxi-
mize the imaging frame rate, and gain was adjusted from a
high level downward to a point where aliasing just disap-
peared. The assessment of tricuspid valve dysfunction was
semiquantitative and reliant on a combination of the continu-
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Table I. Pretransplantation pathologic condition in
201 heart transplant recipients 
No. of patients
Standard Bicaval 
Pretransplantation technique technique 
pathologic condition (n = 105) (n = 96)
Ischemic heart disease 59 63
Cardiomyopathy 33 30
Valve disease 5 8
Other heart conditions 2 1
ous wave and color-flow Doppler findings. In the former, tri-
cuspid valve dysfunction was considered present if blue,
green, or mosaic signals originated from the atrial aspect of
the tricuspid valve during systole. The major criterion for the
severity of regurgitation was qualitative assessment accord-
ing to the ratio of regurgitation jet area, as previously
described. In general, a regurgitation jet area/atrial area of
less than 10% was considered trivial, 10% to 25% was con-
sidered mild, 25% to 50% was considered moderate, and
more than 50% was considered severe. Echocardiographic
assessment was performed in the absence of rejection after
the same policy of hemodynamics assessment. All patients
were in sinus rhythm without cardiac pacing at the time of
echocardiography.
Data analysis. Data are expressed as mean ± standard devi-
ation. Data between the 2 groups were compared with the
Mann-Whitney test, t test, or c 2 where applicable. Survival was
calculated by Kaplan-Meier analysis. In view of possible
changes in transplantation, all investigations were divided into
those performed in 2 eras of transplantation practice. Era 1 was
from April 1991 to April 1994 (38 recipients with the standard
technique and 41 recipients with the bicaval technique) and era
2 from April 1994 to April 1997 (67 recipients with the stan-
dard and 55 recipients with the bicaval technique).
Results
Early postoperative course. The operative mortality
rate was 16% (18/105 cases) for the standard group
versus 6.2% (6/96 patients; P = .03) for the recipients
of the bicaval technique. Ischemic time, donor age, and
implantation times were similar in the 2 groups (Table
II). Hemodynamic parameters recorded during the
early postoperative period are summarized in Table III.
There was no significant difference in the mean aortic
pressure between the 2 groups, but the cardiac index
was significantly higher for the recipients of the bicav-
al technique. The mean RA blood pressure and mean
pulmonary artery (PA) pressures were significantly
lower in the recipients of the bicaval technique (Table
III). Pulmonary wedge pressure was also lower but not
significantly different for the bicaval group during the
early postoperative period (P = .1). The mean ventila-
tion time in hours and the hours of intensive care stay
were shorter for the recipients of the bicaval technique
compared with the recipients of the standard technique
(P = .001 and P = .01, respectively). Analysis of the
results per era revealed that the cardiac index (CI) for
the recipients of the bicaval technique (CI, 3.7 ± 1.1
L/m2 for era 1; CI, 3.87 ± 0.5 L/m2 for era 2) was sig-
nificantly higher than that of recipients of the standard
technique during the same periods (CI, 2.56 ± 0.2 L/m2
for era 1; CI, 2.48 ± 0.6 for era 2; P = .02 and P = .03,
respectively, for the difference between techniques dur-
ing each era). RA and mean PA pressures were signifi-
cantly lower in the recipients of the bicaval technique
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Table II. Preoperative parameters in the recipients of
the standard and bicaval techniques before heart
transplantation
Standard Bicaval 
technique technique P value
Age (y) 49 ± 9.9 47 ± 11.2 .7
Sex (F/M) 17/105 12/96 .06
Before transplantation
IABP (n) 11/105 12/96 .08
Inotropic drugs (n) 18/105 20/96 .6
Ventilation (n) 1/105 2/96 .8
Previous heart surgery (n) 21/105 18/96 .7
EF (%) 15.1 ± 4.9 15.9 ± 5.1 .6
RA pressure 14.0 ± 6.0 15.0 ± 8.0 .9
(mm Hg ± mean)
PA pressure 33.0 ± 8.2 33.0 ± 9.8 .8
(mm Hg ± mean)
TPG (mm Hg) 8.1 ± 3.8 8.0 ± 3.7 .9
PVR (Wood units) 2.5 ± 1.1 2.6 ± 1.3 .9
PCWP (mm Hg) 22.6 ± 9.2 24.4 ± 9.1 .8
Ischemic time (min) 179.0 ± 39.0 182.0 ± 40.0 .8
Implant time (min) 58.0 ± 9.5 60.0 ± 10.0 .8
Donor age (y) 33.6 ± 8.7 32.1 ± 10.5 .8
IABP, Intra-aortic balloon pump; EF%, ejection fraction; TPG, transpul-
monary gradient; PVR, pulmonary vascular resistence; PCWP, pulmonary
capillary wedge pressure.
Table III. Right heart catheter measurements in
recipients of the standard and bicaval techniques after
transplantation
Standard Bicaval 
technique technique 
Parameters (n = 105) (n = 96) P value
Aortic pressure 71.0 ± 14 68.0 ± 16 .6
(mm Hg)
Cardiac index 2.5 ± 0.5 3.8 ± 0.9 .02
RA pressure 13.7 ± 3.2 7.9 ± 2.9 .01
(postop; mm Hg)
RA 4 (mm Hg) 11.7 ± 2.6 5.7 ± 4.6 .001
RA 12 (mm Hg) 10.9 ± 4.8 4.3 ± 4.0 .001
RV 4 (mm Hg) 36.0 ± 7.9 28.0 ± 6.2 .001
RV 12 (mm Hg) 32.0 ± 5.9 27.0 ± 6.9 .02
Mean PA* 27.9 ± 5.6 22.1 ± 5.3 .002
(postop; mm Hg)
Mean PA 4† (mm Hg) 23.6 ± 4.2 17.3 ± 4.8 .001
Mean PA 12‡ (mm Hg) 22.5 ± 5.2 17.5 ± 5.3 .01
RA 4, RA pressure at 4 weeks after transplantation; RA 12, RA pressure at 12
months after transplantation; RV 4, right ventricular pressure at 4 weeks; RV
12, systolic right ventricular pressure 12 months after operation.
*Mean PA pressure before surgery.
†Mean PA pressure 4 weeks after transplantation.
‡Mean PA pressure 12 months after transplantation.
during era 1 (RA, 7.8 ± 2.8 mm Hg; PA, 22.6 ± 4.4 mm
Hg) compared with the recipients of the standard tech-
nique that was performed during the same era (RA,
12.8 ± 3.9 mm Hg; PA, 27.5 ± 5.8 mm Hg; P = .01 and
.001, respectively). During era 2, the right heart pres-
sures were also lower for the recipients of the bicaval
technique (RA, 7.9 ± 3.1 mm Hg; PA, 21.7 ± 5.6 mm
Hg) than for the recipients of the standard technique
performed during the same era (RA, 13.9 ± 2.9 mm Hg;
PA, 28.0 ± 5.5 mm Hg; P = .01 and .002, respectively).
Average ventilation time and intensive therapy unit
(ITU) stay were shorter for patients in era 2 with both
techniques but still significantly longer for the recipi-
ents of the standard technique. During era 1, mean ven-
tilation time was 69 ± 45 hours and mean ITU stay was
84 ± 60 hours for the recipients of the bicaval technique
compared with 89 ± 72 hours and 134 ± 48 hours for
the recipients of the standard technique (P = .002 and
.007, respectively). During era 2, mean ventilation time
was 58 ± 42 hours, and mean ITU stay was 79 ± 45
hours for the recipients of the bicaval technique com-
pared with mean ventilation time of 74 ± 66 hours and
ITU stay of 107 ± 60 hours for the recipients of the
standard technique (P = .001 and .02, respectively). 
Four-week period. Four weeks after transplantation,
the right-sided filling pressures (RA, right ventricular,
and mean pulmonary) were higher for the standard
group (Table III). The pulmonary capillary wedge pres-
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Fig 1. Mann-Whitney-Wilcoxon rank to compare the left ventricular ejection fraction between the recipients of
the bicaval and standard techniques at different intervals.
Fig 2. Prevalence and severity of tricuspid valve dysfunction after heart transplantation in recipients of the stan-
dard and bicaval techniques.
sure was also lower for the recipients of the bicaval
technique (P = .03).
Transthoracic echocardiogram was performed for
each surviving recipient, and it revealed improved
mean ejection fraction for the bicaval group (P = .004). 
Tricuspid valve regurgitation was observed in 80%
(70/87 patients) in the standard versus 63% (57/91
patients) in recipients of the bicaval technique (P =
.008). The prevalence of moderate to severe tricuspid
valve dysfunction was higher for the standard tech-
nique (31/87 patients [35%]) versus those patients who
underwent the bicaval technique (19/91 patients [21%];
P = .02). The incidence of rejection was similar in the
2 groups (71 patients from the standard group and 76
patients from the bicaval group [P = .9]).
One- and two-year periods. Twelve months after
the transplantation, the intracardiac pressures (RA and
mean pulmonary pressures) were significantly lower
for the recipients of the bicaval technique (Table III).
The pulmonary wedge pressure was lower in the recip-
ients of the bicaval technique (P = .04).
The left ventricular ejection fraction was also better
for this group (P = .02) (Fig 1). 
Thirty-five percent of recipients (27/78 cases) in the
standard technique had moderate to severe tricuspid
valve dysfunction versus 17% (15/87 cases) of the
bicaval group (P = .015; Fig 2).
Analysis of the data with respect to era revealed con-
stantly lower RA and pulmonary pressures after 1 year
for the recipients of the bicaval technique than for recip-
ients of the standard technique in both eras. For the
recipients of the bicaval technique, the RA pressure was
4.03 ± 4.1 mm Hg during era 1 and 4.6 ± 4.0 mm Hg for
era 2 versus 10.7 ± 4.1 for era 1 and 11.1 ± 3.9 mm Hg
during era 2 for the recipients of the standard technique
(P = .002 and .001, respectively, for differences
between techniques during era 1 and era 2). Mean PA
pressure for the bicaval group was 17.6 ± 4.3 mm Hg
during era 1 and 17.4 ± 5.8 mm Hg during era 2 com-
pared with 22.8 ± 5.1 mm Hg and 21.9 ± 5.8 mm Hg
during era 1 and era 2, respectively, for the recipients of
the standard technique (P = .01 and .008, respectively). 
At 2 years after transplantation, the mean left ven-
tricular ejection fraction was better preserved for the
recipients of the bicaval technique than for the recipi-
ents of the standard technique (P = .014). Thirty-two
percent of recipients (22/69 cases) with the standard
technique showed significant (moderate or severe) tri-
cuspid valve dysfunction versus 16% (13/80 cases) in
the recipients of the bicaval technique (P = .031; Fig 2).
Recent follow-up. After a mean follow-up period of
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Fig 3. Actuarial survival between recipients of standard and bicaval heart transplants.
Table IV. Causes of death at 60 months after trans-
plantation in the recipients of the standard and bicaval
techniques
Standard Bicaval 
Cause of death (n = 105) (n = 96) P value
Hospital 18 6 .03
Cardiac 13 3 .01
Infection 2 3 .6
Cancer 2 2 .9
Renal failure 2 2 .9
Others 2 3 .6
39 ± 21 months for the standard technique and 46 ± 19
months for the bicaval technique, the echocardiograph-
ic study recorded persistent improved mean left ven-
tricular ejection fraction for the recipients of the bicav-
al technique (P = .005). Recipients with the bicaval
technique have shown lower incidence and severity of
tricuspid valve dysfunction after orthotopic heart trans-
plantation. Moderate or severe tricuspid valve dysfunc-
tion was recorded in 7% of the patients who underwent
the bicaval versus 28% of recipients who underwent the
standard technique of heart transplantation (P = .018).
The incidence of tricuspid valve dysfunction was high-
er in recipients of the standard technique, regardless of
the era of transplantation. Moderate or severe tricuspid
valve dysfunction was recorded in 30% and 26% of the
recipients of the standard technique compared with 9%
and 6.5% in the recipients of the bicaval technique per-
formed during era 1 and era 2, respectively (P = .02 and
.016, respectively). There was no difference between
the incidence and severity of rejection between the 2
groups at any stage after the transplantation. The inci-
dence of rejection episodes was 4.2 ± 0.6 for the stan-
dard group and 4.1 ± 0.7 for the bicaval group (P = .9).
Survival. The actuarial survival at 1, 3, and 5 years
was 74%, 70%, and 62% for standard technique versus
87%, 82%, and 80% for the bicaval technique (P =
.028, .033, and .018, respectively). Death from cardiac
causes was significantly higher for the recipients of the
standard technique (Table IV; Fig 3). Analysis of sur-
vival per era revealed generally improved operative sur-
vival for both techniques during era 2. However, there
was a persistence of marginally better results for the
recipients of the bicaval technique. During era 1, oper-
ative mortality was 4 of 41 patients (11%) for recipients
of the bicaval technique compared with 7 of 38 patients
(18%) for the recipients of the standard technique (P =
.3). In era 2, operative mortality for the recipients of the
bicaval technique was 2 of 55 patients (3.5%) com-
pared with 11 of 67 patients (16%) for recipients of the
standard technique performed during the same era (P =
.041). Persistent right-sided failure was responsible for
most operative deaths in both techniques (5/6 patients
for the bicaval technique; 14/18 patients for the stan-
dard technique). 
Discussion
Results from our study illustrate the early and long-
term influence of the surgical technique on right-sided
hemodynamics, left ventricular function, and tricuspid
valve function after heart transplantation. Immediately
after heart transplantation in most patients, the right
ventricle is exposed to elevated pulmonary pressure
with the risk of acute right ventricular failure because
of the afterload mismatch. Thus surgical technique
leaving the right atrium intact with subsequent preser-
vation of the RA function to enhance net stroke volume
may have a positive effect on right ventricular function.
Normal atrial pump function contributes up to 20% of
the stroke volume.10,11 Because asynchronous contrac-
tion of recipient and donor atria and abnormal atrial
size is a common finding after standard transplantation,
atrial contribution to stroke volume might be dimin-
ished.4 In contrast to the standard technique, the bicav-
al technique offers a more physiologic RA size12 and
contraction pattern throughout the cardiac cycle.13
The difference in the physiologic condition on the
right side between the 2 techniques during the early
postoperative period has been previously investigated.
Diminished forward systolic flow in the superior vena
cava has been demonstrated in patients undergoing
transplantation by the standard technique, with similar
systolic forward and diastolic flows for recipients of
the bicaval technique.14 Diminished forward systolic
vena caval flow has also been described in restrictive
ventricular pathologic findings such as cardiomyopa-
thy15 and acute cardiac rejection, and this pattern of
abolished forward systolic vena caval flow has been
proposed as a sign of acute cardiac rejection.16 The dif-
ference between the 2 techniques with respect to vena
caval forward flow is likely to be related to the differ-
ences in RA size and performance. An increased late
diastolic tricuspid flow in the patient with the bicaval
technique indicated more vigorous RA contraction fol-
lowed by better atrial relaxation, with increased for-
ward vena caval flow during subsequent ventricular
systole.17 In contrast, RA contraction may be less vig-
orous in recipients of the standard technique as a result
of atrial sutures and greater size.
Generally, tricuspid valve dysfunction is reported to be
highly prevalent both immediately and late after ortho-
topic heart transplantation.4-18,19 Theories to explain this
include acute allograft edema (which diminishes with
time),20 papillary muscle dysfunction,21 preoperative
annular dilatation,22 disturbed geometry of the RA anas-
tomosis with subsequent impairment of the functional
integrity of the valvular apparatus,18 possibly cyclic tor-
sion of the atria during ventricular systole and diastole,18
asynchronous contraction of the donor and recipient atri-
al compartment,20 and biopsy-induced flail tricuspid
valve.23 Alteration in the right ventricular structure may
also contribute to the occurrence of tricuspid valve dys-
function because a significantly greater percentage of
patients with post-transplantation right ventricular
enlargement have been found to have moderate tricuspid
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valve dysfunction.24 Using the bicaval Wythenshawe
technique, we have noted a marked reduction in early
and late postoperative significant (moderate or severe)
tricuspid valve dysfunction compared with patients
undergoing transplantation with the standard technique.
Of note is the fact that 50% of recipients with a severe
degree of tricuspid valve dysfunction in our series (all
from the group undergoing standard transplantation) had
symptoms related to chronic right ventricular volume
overload and their right-sided pressures were signifi-
cantly elevated at the end of the first year after the trans-
plantation. 
Right and left ventricular performance after trans-
plantation are affected by the surgical technique, and
depressed right ventricular function with the standard
technique has been documented as the result of signif-
icantly increased right ventricular volume and distor-
tion of the right ventricular free wall relative to the
interventricular septum.25 The echocardiographic
analysis of cardiac transplant recipients in whom stan-
dard technique was used showed an enlarged right ven-
tricular cavity and dilatation caused by distortion of the
right ventricular free wall relative to the interventricu-
lar septum was shown by a significant increase in the
septum–to–right ventricular free wall dimensions.25
The improvement in the right-sided hemodynamics
for the recipients of the bicaval technique reflects
improvement in their right ventricular function for this
group of patients. Several reasons could explain this:
improved atrial geometry with reduction in the inci-
dence of tricuspid valve12,26-28 and improved right ven-
tricular dimensions (right ventricular end-diastolic area)
have been also reported in transplant recipients with the
bicaval technique.29 Superior right and left ventricular
diastolic function30 in recipients with bicaval technique
contribute to improved right ventricular and mean PA
compliance in the recipients of the bicaval technique.
The improvement of the left-sided performance dur-
ing the early postoperative period after heart transplan-
tation has also been reported6,7 after the use of the
bicaval technique. Reduced left and right ventricular
isovolumic relaxation times in patients who underwent
transplantation by the bicaval technique probably indi-
cate better relaxation,14 because the RA and the left
atrial pressures were lower in these groups. Previous
studies have reported that a small left atrial cuff with
the bicaval technique lowered the incidence of mitral
valve dysfunction and maintained the atrial contribu-
tion to the left ventricular filling.6-8
Potentially, the differences in survival in our study
could be attributed to era of transplantation. The
International Society for Heart and Lung Trans-
plantation Official Registry31 considers that the period
of 1991 through 1997 is involved in the actual current
practice of transplantation. Half-life after transplanta-
tion was 9.2 years for 1991 compared with 9.4 years for
1997. Analysis of our data at 2 different stages of the
current era (April 1991–April 1994 as era 1; May
1994–April 1997 as era 2) has demonstrated persistent
superior cardiac function and lower incidence of tricus-
pid valve dysfunction in the recipients of the bicaval
technique, which could be the reason behind the
improved survival for the recipients of the bicaval
technique. 
Although the preoperative clinical characteristics that
may have influenced the early postoperative outcome
were not significantly different between the 2 groups
(Table II), a limitation of our study was that that out-
come could have been affected by postoperative clini-
cal features. We did not, however, identify a difference
between the 2 groups in terms of incidence or severity
of rejection episodes, renal dysfunction, or infection,
which are likely to be the major predictors of outcome
after the operation (Table V). Therefore the difference
in clinical outcome between the bicaval and standard
groups is more likely to be attributable to the operative
technique rather than any other factor. 
Several studies have investigated the advantage of the
bicaval technique during the early postoperative period
after orthotopic heart transplantation. Our report illus-
trates the medium-term benefits of the bicaval tech-
nique in heart transplantation. Both right- and left-
sided cardiac function were preserved for more than 5
years after the transplantation with less incidence of
atrioventricular valve regurgitation. Death from cardiac
reasons was lower in the bicaval group.
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Table V. Analysis of first-year confounding factors in
recipients of both standard and bicaval techniques
(renal impairment serum creatinine of more than 200
mmol/L for 4 weeks)
Standard Bicaval 
technique technique 
Confounding factor (n = 105) (n = 96) P value
Cellular rejection (n) 89 90 .9
Humoral rejection (n) 2 3 .9
Infection episode/patient
Bacterial 0.29 ± 0.25 0.24 ± 0.19 .7
Viral 0.11 ± 0.03 0.12 ± 0.04 .8
Fungal 0.006 0.005 .8
Cyclosporine level 163 ± 25 167 ± 21 .8
(mmol/L)
Renal impairment (n) 4 3 .9
This study highlights the importance of preference of
the bicaval technique for orthotopic heart transplanta-
tion, especially in select young patients and, in particu-
lar, those potential transplant recipients with end-stage
cardiac disease. 
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